Replies to post #523117 on NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

The trial was a clinicial success:

https://nwbio.com/presentation-about-phase-3-trial-of-dcvax-l-for-glioblastoma/

Sawston plant can scale up to 12K patients per year:

https://nwbio.com/northwest-biotherapeutics-announces-presentations-on-dcvax-l-personalized-vaccines-manufacturing-and-scale-up-and-dcvax-l-clinical-program/

Final commercial manufacturing license submitted:

https://nwbio.com/northwest-biotherapeutics-announces-filing-of-application-for-license-for-commercial-manufacturing-at-sawston-uk-facility/

MHRA endorsed PIII trial design by applying it to Pediatric Investigation Plan:

https://nwbio.com/northwest-biotherapeutics-announces-approval-of-pediatric-investigation-plan-pip-by-mhra-pip-approval-is-a-pre-requisite-for-application-for-approval-of-a-new-medicine-for-adult-patients/

If you think management are sitting on good data, or not communicating, then you're not paying attention!